NCT00618501 - Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions

Leukemia

Interventions

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

etoposide

DRUG

imatinib mesylate

DRUG

leucovorin calcium

DRUG

methotrexate

DRUG

prednisolone

DRUG

therapeutic hydrocortisone

DRUG

vincristine sulfate

PROCEDURE

allogeneic hematopoietic stem cell transplantation

Trial Locations (1)

Asan Medical Center - University of Ulsan College of Medicine, Seoul